BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33097773)

  • 21. Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.
    Adams EJ; Karthaus WR; Hoover E; Liu D; Gruet A; Zhang Z; Cho H; DiLoreto R; Chhangawala S; Liu Y; Watson PA; Davicioni E; Sboner A; Barbieri CE; Bose R; Leslie CS; Sawyers CL
    Nature; 2020 Sep; 585(7826):E20. PubMed ID: 32895534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
    Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N
    Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
    Carver BS; Tran J; Gopalan A; Chen Z; Shaikh S; Carracedo A; Alimonti A; Nardella C; Varmeh S; Scardino PT; Cordon-Cardo C; Gerald W; Pandolfi PP
    Nat Genet; 2020 Sep; 52(9):984. PubMed ID: 32820258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
    Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
    Nat Commun; 2020 Feb; 11(1):1095. PubMed ID: 32094369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
    Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.
    Simpson BS; Camacho N; Luxton HJ; Pye H; Finn R; Heavey S; Pitt J; Moore CM; Whitaker HC
    Commun Biol; 2020 Oct; 3(1):570. PubMed ID: 33033409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
    Lunardi A; Ala U; Epping MT; Salmena L; Clohessy JG; Webster KA; Wang G; Mazzucchelli R; Bianconi M; Stack EC; Lis R; Patnaik A; Cantley LC; Bubley G; Cordon-Cardo C; Gerald WL; Montironi R; Signoretti S; Loda M; Nardella C; Pandolfi PP
    Nat Genet; 2020 Oct; 52(10):1132. PubMed ID: 32884149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Author Correction: Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer.
    Lello L; Raben TG; Yong SY; Tellier LCAM; Hsu SDH
    Sci Rep; 2019 Nov; 9(1):17515. PubMed ID: 31748697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.
    Ananias HJ; Yu Z; Dierckx RA; van der Wiele C; Helfrich W; Wang F; Yan Y; Chen X; de Jong IJ; Elsinga PH
    Mol Pharm; 2011 Aug; 8(4):1165-73. PubMed ID: 21699202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
    Luszczak S; Simpson BS; Stopka-Farooqui U; Sathyadevan VK; Echeverria LMC; Kumar C; Costa H; Haider A; Freeman A; Jameson C; Ratynska M; Ben-Salha I; Sridhar A; Shaw G; Kelly JD; Pye H; Gately KA; Whitaker HC; Heavey S
    Sci Rep; 2020 Nov; 10(1):19870. PubMed ID: 33177621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.
    Li Q; Liu B; Chao HP; Ji Y; Lu Y; Mehmood R; Jeter C; Chen T; Moore JR; Li W; Liu C; Rycaj K; Tracz A; Kirk J; Calhoun-Davis T; Xiong J; Deng Q; Huang J; Foster BA; Gokhale A; Chen X; Tang DG
    Nat Commun; 2020 Jun; 11(1):2895. PubMed ID: 32499578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Author Correction: An exome-wide rare variant analysis of Korean men identifies three novel genes predisposing to prostate cancer.
    Oh JJ; Shivakumar M; Miller J; Verma S; Lee H; Hong SK; Lee SE; Lee Y; Lee SJ; Sung J; Kim D; Byun SS
    Sci Rep; 2020 Feb; 10(1):2481. PubMed ID: 32034279
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Schmidkonz C; Hollweg C; Beck M; Reinfelder J; Goetz TI; Sanders JC; Schmidt D; Prante O; Bäuerle T; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
    Prostate; 2018 Jan; 78(1):54-63. PubMed ID: 29105797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
    Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
    Sci Rep; 2020 Feb; 10(1):2874. PubMed ID: 32051516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research.
    Omar MI; Roobol MJ; Ribal MJ; Abbott T; Agapow PM; Araujo S; Asiimwe A; Auffray C; Balaur I; Beyer K; Bernini C; Bjartell A; Briganti A; Butler-Ransohoff JE; Campi R; Cavelaars M; De Meulder B; Devecseri Z; Voss MD; Dimitropoulos K; Evans-Axelsson S; Franks B; Fullwood L; Horgan D; Smith EJ; Kiran A; Kivinummi K; Lambrecht M; Lancet D; Lindgren P; MacLennan S; MacLennan S; Nogueira MM; Moen F; Moinat M; Papineni K; Reich C; Reiche K; Rogiers S; Sartini C; van Bochove K; van Diggelen F; Van Hemelrijck M; Van Poppel H; Zong J; N'Dow J;
    Nat Rev Urol; 2020 Aug; 17(8):482. PubMed ID: 32587405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Author Correction: Evaluation of narrow band imaging in the assessment of laryngeal granuloma.
    Klimza H; Pietruszewska W; Jackowska J; Piersiala K; Wierzbicka M
    Sci Rep; 2020 Mar; 10(1):4385. PubMed ID: 32127628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Author Correction: Analysis of laser radiation using the Nonlinear Fourier transform.
    Sugavanam S; Kopae MK; Peng J; Prilepsky JE; Turitsyn SK
    Nat Commun; 2020 Oct; 11(1):5050. PubMed ID: 33009393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Author Correction: Impact of ionizing radiation on superconducting qubit coherence.
    Vepsäläinen AP; Karamlou AH; Orrell JL; Dogra AS; Loer B; Vasconcelos F; Kim DK; Melville AJ; Niedzielski BM; Yoder JL; Gustavsson S; Formaggio JA; VanDevender BA; Oliver WD
    Nature; 2020 Oct; 586(7827):E8. PubMed ID: 32918069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Author Correction: Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction.
    Hsu FS; Chou CW; Chang HC; Tu YP; Sha SJ; Chung HH; Huang KH
    Sci Rep; 2019 Nov; 9(1):17872. PubMed ID: 31767913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT.
    Gosewisch A; Ilhan H; Tattenberg S; Mairani A; Parodi K; Brosch J; Kaiser L; Gildehaus FJ; Todica A; Ziegler S; Bartenstein P; Böning G
    EJNMMI Res; 2019 Aug; 9(1):76. PubMed ID: 31414241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.